Last reviewed · How we verify

NCT05084703

Reproducibility of Functional Shoulder Tests for the Return to Sport of Patients Operated on Previous Shoulder Instability

Status unknown NA Last updated 20 October 2021
What this trial tests

NA trial testing Functional tests in Latarjet in 100 participants. Status unknown.

Timeline
26 April 2019
Primary endpoint
26 April 2021
26 April 2022

Quick facts

Lead sponsorRamsay Générale de Santé
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposediagnostic
Enrollment100
Start date26 April 2019
Primary completion26 April 2021
Estimated completion26 April 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Ramsay Générale de Santé — full company profile →

Who can join

Adults 18 to 30, male only, with Latarjet or Shoulder Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess whether the indicators outcome of these tests discriminate between different populations. In particular to compare populations with shoulders without any history of injury with a population that had undergone a reduction in glenohumeral instability by the Latarjet technique.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Functional tests

Trials testing the same drug.

Other recruiting trials for Latarjet

Currently open trials in the same condition.

Other Ramsay Générale de Santé trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05084703.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing